First Manhattan’s TRANSITION THERAPEUTICS INC (CANADA) TTHI Stock Holding History

First Manhattan’s Portfolio TTHI Stock Details TTHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-666	Closed	-$4K	–	1572
2015 Q1	$4K	Hold	666	–	–	﹤0.01%	1347
2014 Q4	$4K	Hold	666	–	–	﹤0.01%	1372
2014 Q3	$4K	Hold	666	–	–	﹤0.01%	1340
2014 Q2	$4K	Hold	666	–	–	﹤0.01%	1320
2014 Q1	$5K	Hold	666	–	–	﹤0.01%	1275
2013 Q4	$3K	Hold	666	–	–	﹤0.01%	1281
2013 Q3	$2K	Hold	666	–	–	﹤0.01%	1316
2013 Q2	$2K	Buy	+666	New	+$1.89K	﹤0.01%	1313

Other funds holding TTHI

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HCM

Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

First Manhattan's TTHI Position: Q2 2015 in Review

First Manhattan sold out of TRANSITION THERAPEUTICS INC (CANADA) (TTHI) in Q2 2015, closing a stake of 666 shares — an estimated $4K sold.

First Manhattan first reported a position in TTHI in Q2 2013 and held it in 8 quarters. The position peaked at $5K in Q1 2014. 30 funds tracked by Wall St. Rank hold TTHI as of Q2 2015.

First Manhattan reported no remaining TRANSITION THERAPEUTICS INC (CANADA) position as of Q2 2015 after selling out during the quarter.
First Manhattan sold 666 TRANSITION THERAPEUTICS INC (CANADA) shares in Q2 2015, an estimated $4K.
First Manhattan first reported a position in TRANSITION THERAPEUTICS INC (CANADA) in Q2 2013 and held it in 8 quarters.
First Manhattan's TRANSITION THERAPEUTICS INC (CANADA) position peaked at $5K in Q1 2014.
30 funds tracked by Wall St. Rank held TRANSITION THERAPEUTICS INC (CANADA) as of Q2 2015.

Based on First Manhattan's 13F filing for Q2 2015, filed 17 Jul 2015.